Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cancer Investigation|August 7, 2001
The molecular biology of cervical cancerJ K Wolf, P T Ramirez
Oncology Reports|April 4, 1998
Distinctive karyotypes and growth patterns in nude mice reveal cross-contamination in an established human cancer cell lineJ E Price, J K Wolf, S Pathak
Annals of Clinical and Laboratory Science|October 25, 2000
Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell linesL P Parker, J K Wolf, J E Price
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
Laparoscopic port-site metastases in patients with gynecological malignanciesP T Ramirez, M Frumovitz, J K Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancerL Ramondetta, G B Mills, T W Burke, et al.
Oncology Reports|July 31, 1998
Epidermal growth factor receptor (EGFR) antisense transfection reduces the expression of EGFR and suppresses the malignant phenotype of a human ovarian cancer cell lineK R Brader, J K Wolf, S Chakrabarty, et al.
Gynecologic Oncology|January 4, 2001
Low-grade ovarian cancer in an adolescent patientL P Parker, P T Ramirez, R Broaddus, et al.
Cancer Research|February 15, 1993
Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1AD Yu, J K Wolf, M Scanlon, et al.
Obstetrics and Gynecology|July 1, 1996
Adenocarcinoma in situ of the cervix: significance of cone biopsy marginsJ K Wolf, C Levenback, A Malpica, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancerS C Modesitt, P Ramirez, Z Zu, et al.
Pageof 3